A flurry of new research findings on a vaccine that prevents persistent infections by cancer-causing types of the human papillomavirus (HPV) has confirmed the vaccine's efficacy and opened new avenues for research. The results, published in three separate reports, suggest that the vaccine could be simpler to administer and more affordable than researchers had thought previously—and the vaccine may also have unexpected benefits. Read more > >
The director of NCI's new Center for Global Health explains why the center was formed and discusses the institute's global strategy for engaging the research community and other partners worldwide to ensure that cancer research has a global reach.
- Health Officials Issue Statement on Drug Shortages
- Cancer Therapies Office Reorganized
- NCI Recovery Act Website Highlights Training in Comparative Effectiveness Research
- Appointments Announced for Two New NCI Centers, Division of Cancer Prevention
- NCI's Norm Coleman Wins Service to America Medal
- Director's Consumer Liaison Group Meets this Week
- NCI, HHS Launch Mobile Services to Help Smokers Quit
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at email@example.com.